Transplantation of kidneys with tumors

Area of Science:

• Nephrology
• Oncology
• Transplantation Surgery

Background:

• Increasing renal transplant waitlists necessitate innovative donor sourcing strategies.
• Utilizing kidneys with incidental or intentionally removed tumors is one such strategy.
• Careful patient selection and tumor characterization are crucial for safety.

Purpose of the Study:

• To evaluate the safety and feasibility of transplanting kidneys with tumors.
• To assess the risk of tumor recurrence in recipients of such grafts.
• To establish criteria for selecting suitable kidney donors with tumors.

Main Methods:

• Review of current evidence on transplanting kidneys with renal cell carcinoma (RCC).
• Analysis of tumor characteristics (size, grade, differentiation) and excision techniques.
• Assessment of recipient outcomes, focusing on tumor recurrence rates.

Main Results:

• Solitary, well-differentiated RCC (Fuhrman grade I-II), <1 cm, resected before grafting presents minimal recurrence risk.
• Transplantation of such kidneys is a viable option to increase organ availability.
• Informed consent regarding potential risks is mandatory for recipients.

Conclusions:

• Transplanting kidneys with specific types of small renal tumors is a safe and effective strategy to mitigate donor organ shortages.
• Careful pre-transplant evaluation and surgical excision of the tumor are key to minimizing recipient risk.
• Patient education and consent are paramount when considering these specialized renal grafts.